Applied DNA Sciences, through its subsidiary Applied DNA Clinical Labs (ADCL), has expanded its clinical testing services for mpox, leading to a 37% surge in its stock price. The new service now includes detection of both Mpox Clade I and Clade II, aiming to bolster efforts to combat the rising mpox threat.
Results for: APPLIED DNA SCIENCES
Applied DNA Sciences (APDN) saw its stock price surge on Friday after submitting a validation package to the New York State Department of Health (NYSDOH) for its Linea Mpox Virus 1.0 Assay. The company seeks to expand the assay’s use to detect both clade I and clade II of the mpox virus, potentially increasing its testing capabilities and revenue.
Nikola Corporation’s stock plummeted after announcing a securities purchase agreement and a mixed shelf offering. Meanwhile, Alzamend Neuro surged 262% on news of a partnership with Massachusetts General Hospital for a Phase II clinical study of its PTSD treatment. Other notable movers include Virax Biolabs, Applied DNA Sciences, and Sonder Holdings.